Ulcerative colitis and Crohns disease studies

To enable us to assess your suitability for upcoming clinical trials please answer the following questions:


Are you 18 to 80 years old with ulcerative colitis OR 16-80 years old with Crohn's disease


Did you have a diagnosis of ulcerative colitis or Crohn's disease with the start of symptoms at least 3 months ago


Currently have symptoms of UC or CD


Have you found that conventional treatments did not work well for you



Crohn’s disease and ulcerative colitis, also known as inflammatory bowel disease (IBD), are chronic, recurring and remittent conditions. The symptoms of IBD can be painful and exhausing and lead to impaired quality of life.

Crohn’s disease’s and ulcerative colitis, otherwise known as inflammatory bowel disease, is a chronic condition which affects the digestive system. The symptoms can be very painful and exhausting

Crohn’s disease and ulcerative colitis are chronic conditions which involve inflammation of the intestinal canal collectively known as inflammatory bowel disease (IBD). Ulcerative colitis only affects the colon whereas Crohn’s disease can affect any part of the digestive system.

Symptoms of IBD include:

  • Regular urgency to empty the bowels
  • Pain, cramps or swelling of the stomach
  • Repeated or bloody diarrhoea
  • Weight loss
  • Extreme tiredness
18-80 with Ulcerative colitis and 16-80 with Crohn's disease
Male and female
Inflammatory bowel disease

As one of the largest and most recognised clinical study organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself. A clinical trial offers an opportunity to help researchers find better treatments for others in the future.

All Synexus studies are approved by an independent ethics committee.

Recruiting at the following locations

Helderberg Clinical Research Centre: Somerset West Quick view

Still unsure?

Feel free to call us on 0861 796 398 to find out more about this study.


Your feedback is vital to the success of our research. Please fill in the form fields below.